Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
- PMID: 33266503
- PMCID: PMC7700648
- DOI: 10.3390/cancers12113476
Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
Abstract
While viewed as the "guardian of the genome", the importance of the tumor suppressor p53 protein has increasingly gained ever more recognition in modulating additional modes of action related to cell death. Slowly but surely, its importance has evolved from a mutated genetic locus heavily implicated in a wide array of cancer types to modulating lysosomal-mediated cell death either directly or indirectly through the transcriptional regulation of the key signal transduction pathway intermediates involved in this. As an important step in determining the fate of cells in response to cytotoxicity or during stress response, lysosomal-mediated cell death has also become strongly interwoven with the key components that give the lysosome functionality in the form of the cathepsin proteases. While a number of articles have been published highlighting the independent input of p53 or cathepsins to cellular homeostasis and disease progression, one key area that warrants further focus is the regulatory relationship that p53 and its isoforms share with such proteases in regulating lysosomal-mediated cell death. Herein, we review recent developments that have shaped this relationship and highlight key areas that need further exploration to aid novel therapeutic design and intervention strategies.
Keywords: MOMP; apoptosis; cancer; cathepsin; lysosomal membrane permeabilization; p53.
Conflict of interest statement
There are no conflict of interest.
Figures
Similar articles
-
'Patchiness' and basic cancer research: unravelling the proteases.Cell Cycle. 2019 Aug;18(15):1687-1701. doi: 10.1080/15384101.2019.1632639. Epub 2019 Jun 24. Cell Cycle. 2019. PMID: 31213124 Free PMC article. Review.
-
Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer.Cancers (Basel). 2020 Nov 20;12(11):3454. doi: 10.3390/cancers12113454. Cancers (Basel). 2020. PMID: 33233599 Free PMC article. Review.
-
Lysosomal cysteine cathepsins: signaling pathways in apoptosis.Biol Chem. 2007 Jun;388(6):555-60. doi: 10.1515/BC.2007.064. Biol Chem. 2007. PMID: 17552902 Review.
-
Lysosomal membrane permeabilization in cell death.Oncogene. 2008 Oct 27;27(50):6434-51. doi: 10.1038/onc.2008.310. Oncogene. 2008. PMID: 18955971 Review.
-
The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation.Arch Biochem Biophys. 2019 Jul 30;670:32-42. doi: 10.1016/j.abb.2019.02.015. Epub 2019 Feb 23. Arch Biochem Biophys. 2019. PMID: 30807742 Review.
Cited by
-
Etomidate inhibits cell proliferation and induces apoptosis in A549 non-small cell lung cancer cells via downregulating WWP2.Exp Ther Med. 2021 Nov;22(5):1254. doi: 10.3892/etm.2021.10689. Epub 2021 Sep 3. Exp Ther Med. 2021. PMID: 34603522 Free PMC article.
-
The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211033044. doi: 10.1177/15330338211033044. Technol Cancer Res Treat. 2021. PMID: 34278852 Free PMC article. Review.
-
Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis.Pharmaceutics. 2021 Mar 5;13(3):339. doi: 10.3390/pharmaceutics13030339. Pharmaceutics. 2021. PMID: 33807987 Free PMC article.
-
Cathepsin D-Managing the Delicate Balance.Pharmaceutics. 2021 Jun 5;13(6):837. doi: 10.3390/pharmaceutics13060837. Pharmaceutics. 2021. PMID: 34198733 Free PMC article. Review.
-
Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis.Int J Mol Sci. 2021 Apr 28;22(9):4669. doi: 10.3390/ijms22094669. Int J Mol Sci. 2021. PMID: 33925117 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous